Cathay Biotech (China) Analysis

Cathay Stock Analysis Notes

About 61.0% of the company shares are owned by insiders or employees . The book value of Cathay Biotech was presently reported as 19.74. The company last dividend was issued on the 24th of July 2024. Cathay Biotech had 1.4:1 split on the 20th of July 2022. For more info on Cathay Biotech please contact Xiucai Liu at 86 21 5080 1916 or go to https://www.cathaybiotech.com.

Cathay Biotech Investment Alerts

Cathay Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 26.47 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cathay Biotech's market, we take the total number of its shares issued and multiply it by Cathay Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Cathay Profitablity

The company has Profit Margin (PM) of 0.14 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.2 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.2.

Management Efficiency

Cathay Biotech has return on total asset (ROA) of 0.0106 % which means that it generated a profit of $0.0106 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.026 %, meaning that it generated $0.026 on every $100 dollars invested by stockholders. Cathay Biotech's management efficiency ratios could be used to measure how well Cathay Biotech manages its routine affairs as well as how well it operates its assets and liabilities. At present, Cathay Biotech's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 8.5 B, whereas Total Assets are forecasted to decline to about 15.6 B.

Technical Drivers

As of the 11th of December 2024, Cathay Biotech shows the Downside Deviation of 2.68, mean deviation of 2.59, and Risk Adjusted Performance of 0.0828. Cathay Biotech technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Cathay Biotech Price Movement Analysis

Cathay Biotech Outstanding Bonds

Cathay Biotech Predictive Daily Indicators

Cathay Biotech Forecast Models

Cathay Biotech's time-series forecasting models are one of many Cathay Biotech's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cathay Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Cathay Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cathay shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Cathay Biotech. By using and applying Cathay Stock analysis, traders can create a robust methodology for identifying Cathay entry and exit points for their positions.

When running Cathay Biotech's price analysis, check to measure Cathay Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cathay Biotech is operating at the current time. Most of Cathay Biotech's value examination focuses on studying past and present price action to predict the probability of Cathay Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cathay Biotech's price. Additionally, you may evaluate how the addition of Cathay Biotech to your portfolios can decrease your overall portfolio volatility.